CORVIDIA THERAPEUTICS INC has a total of 15 patent applications. Its first patent ever was published in 2018. It filed its patents most often in Brazil, Israel and United States. Its main competitors in its focus markets pharmaceuticals and biotechnology are FRIESS THOMAS, NANJING ANJI BIOLOGICAL SCIENCE & TECH CO LTD and KARYON OY.
# | Country | Total Patents | |
---|---|---|---|
#1 | Brazil | 2 | |
#2 | Israel | 2 | |
#3 | United States | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Canada | 1 | |
#6 | Chile | 1 | |
#7 | China | 1 | |
#8 | Colombia | 1 | |
#9 | EPO (European Patent Office) | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Kakkar Rahul | 10 |
#2 | Davidson Michael H | 8 |
#3 | Devalaraja Madhav N | 8 |
#4 | Devalaraja Madhav | 3 |
#5 | Madhav N Devalaraja | 2 |
#6 | Davidson Michael | 2 |
#7 | Alan Thomas Remaley | 1 |
#8 | Rahul Kakkar | 1 |
#9 | Soumitra Shanker Ghosh | 1 |
#10 | Zhu Gaozhong | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020223565A1 | Anti-il-6 antibody formulation | |
SG11202006157VA | Methods for treating il-6 mediated inflammation without immunosuppression |